W
MED icon

WealthCollab’s Medifast MED Stock Holding History

WealthCollab’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-110
Closed -$1.12K – 1026
2026
Q1 		$1.12K Sell
110
-229
-68% -$2.47K ﹤0.01% 902
2025
Q4 		$3.62K Buy
339
+163
+93% +$1.95K ﹤0.01% 789
2025
Q3 		$2.41K Buy
176
+86
+96% +$1.2K ﹤0.01% 802
2025
Q2 		$1.26K Buy
90
+63
+233% +$828 ﹤0.01% 875
2025
Q1 		$364 Sell
27
-509
-95% -$7.64K ﹤0.01% 891
2024
Q4 		$9.45K Buy
536
+78
+17% +$1.45K 0.01% 457
2024
Q3 		$8.77K Sell
458
-254
-36% -$4.89K 0.01% 491
2024
Q2 		$15.5K Sell
712
-76
-10% -$2.03K 0.01% 344
2024
Q1 		$30.2K Buy
788
+634
+412% +$30.7K 0.02% 222
2023
Q4 		$10.4K Buy
+154
New +$10.7K 0.01% 406

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

WealthCollab's MED Position: Q2 2026 in Review

WealthCollab sold out of Medifast (MED) in Q2 2026, closing a stake of 110 shares — an estimated $1.12K sold.

WealthCollab first reported a position in MED in Q4 2023 and held it in 10 quarters. The position peaked at $30.2K in Q1 2024. 112 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • WealthCollab reported no remaining Medifast position as of Q2 2026 after selling out during the quarter.
  • WealthCollab sold 110 Medifast shares in Q2 2026, an estimated $1.12K.
  • WealthCollab first reported a position in Medifast in Q4 2023 and held it in 10 quarters.
  • WealthCollab's Medifast position peaked at $30.2K in Q1 2024.
  • 112 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.